EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Folic acid‐decorated astrocytes‐derived exosomes enhanced the effect of temozolomide against glioma

Hong-Ming Liu, Ye Zhang iD

The Kaohsiung Journal of Medical Sciences · 2024

DOI: 10.1002/kjm2.12819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2024. Verfasst von Hong-Ming Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Center For Food and Drug Evaluation & Inspection, Jinan, China. Hauptthemen laut MEDLINE: Temozolomide, Folic Acid, Exosomes, Glioma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A direct strategy to achieve specific treatments and reduce side effects is through cell type‐specific drug delivery. Exosomes (Exos) can be modified with folic acid (FA) to prepare drug delivery systems targeting tumor cells that highly express FA receptors. This study aimed to produce an exo drug delivery system with FA decoration and temozolomide (TMZ) loading to improve the sustained TMZ release and targeting. We used DSPE‐PEG 2000 ‐FA to modify exos derived from astrocyte U‐87 to prepare FA‐modified exos (Astro‐exo‐FA). TMZ was encapsulated into Astro‐exo‐FA or Astro‐exo through electroporation to produce TMZ@Astro‐exo and TMZ@Astro‐exo‐FA. In vitro drug release was examined using the dialysis bag method. Through cell experiments in vitro and mouse glioma models in vivo, the effect of TMZ@Astro‐exo‐FA on U‐87 cells was determined. Exo properties were not affected by FA modification and TMZ loading. The drug release rate of TMZ@Astro‐exo‐FA was slower. TMZ@Astro‐exo‐FA uptake by U‐87 cells was higher compared to TMZ@Astro‐exo, indicating that TMZ@Astro‐exo‐FA has a stronger targeting toward U‐87 cells. TMZ@Astro‐exo‐FA remarkably reduced U‐87 cell proliferation, migration, and invasion compared with TMZ@Astro‐exo and free TMZ. Treatment with TMZ@Astro‐exo‐FA reduced the side effects of TMZ (minimal change in body weight), prolonged survival, and inhibited tumor growth in mouse glioma models, and its efficacy was stronger than that of TMZ@Astro‐exo and free TMZ. TMZ@Astro‐exo‐FA could enhance the effect of TMZ against glioma, providing novel ideas for drug targeting delivery and exploring exos as drug carriers against glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideFolic AcidExosomesGliomaAstrocytesAnimalsMiceCell Line, TumorHumansDrug Delivery SystemsDrug LiberationCell ProliferationBrain NeoplasmsXenograft Model Antitumor AssaysDrug Carriers

Stichwörter der Autor:innen

astrocytesexosomesfolic acidgliomatemozolomide

Substanzen

TemozolomideFolic AcidDrug Carriers

Autor:innen und Institutionen

  • Shandong Center For Food and Drug Evaluation & Inspection, Jinan, China.
  • Zibo Food and Drug Inspection and Research Institute, Zibo, China.
  • Department of Pharmaceutical Science, Zibo Vocational Institute, Zibo, China.

ORCID-Profile: Ye Zhang

Zitieren

APA

Liu, H. M., & Zhang, Y. (2024). Folic acid‐decorated astrocytes‐derived exosomes enhanced the effect of temozolomide against glioma. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.12819

Vancouver

Liu HM, Zhang Y. Folic acid‐decorated astrocytes‐derived exosomes enhanced the effect of temozolomide against glioma. The Kaohsiung Journal of Medical Sciences. 2024. doi:10.1002/kjm2.12819

BibTeX
@article{Liu2024,
  author = {Liu, Hong-Ming and Zhang, Ye},
  title = {Folic acid‐decorated astrocytes‐derived exosomes enhanced the effect of temozolomide against glioma},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2024},
  doi = {10.1002/kjm2.12819}
}
Kostenlos starten →